Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

The U.S.-Saudi Arabia investment forum to take place in Washington during the visit of Saudi Crown Prince Mohammed bin Salman ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...

(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, as per preliminary ...

The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM ESTCompany ParticipantsDavid Denton - Executive VP ...

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

Pfizer eventually increased its offer. The company is now set to acquire Metsera in a deal worth up to $10 billion, including ...

Right now, that's none other than Eli Lilly (NYSE: LLY). However, others are looking to challenge its dominance. Recent comments from Pfizer 's (NYSE: PFE) CEO, Albert Bourla, suggest it could become ...